Search

Author/Creator Lupton, Stephanie

2. Implications for sequencing of biologic therapy and choice of second anti‐TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti‐TNF therapy (IMSAT) therapeutic drug monitoring study. Issue 8 (29th August 2022)

Authors:
Chanchlani, Neil; Lin, Simeng; Auth, Marcus K.; Lee, Chai Leng; Robbins, Helena; Looi, Shi; Murugesan, Senthil V.; Riley, Tom; Preston, Cathryn; Stephenson, Sophie; Cardozo, Wendy; Sonwalkar, Sunil A.; Allah‐Ditta, Mohammed; Mansfield, Lynne; Durai, Dharmaraj; Baker, Mark; London, Ian; London, Em...
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 56:Issue 8(2022)
Page Start:
1250
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study. (February 2023)

Authors:
Liu, Zhigang; Le, Kaixing; Zhou, Xin; Alexander, James L; Lin, Simeng; Bewshea, Claire; Chanchlani, Neil; Nice, Rachel; McDonald, Timothy J; Lamb, Christopher A; Sebastian, Shaji; Kok, Klaartje; Lees, Charlie W; Hart, Ailsa L; Pollok, Richard C; Boyton, Rosemary J; Altmann, Daniel M; Pollock, Kat...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 8:Number 2(2023)
Page Start:
145
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗